journalEvidence level BIndependent
Evidence pageQuality standards for NK cell immunotherapies
Frontiers in Bioengineering and Biotechnology (von Werz et al.)
accessed Nov 10, 2026Updated Nov 10, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC12644036/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Independent of the subject |
| Evidence level | B · Peer-reviewed or professional body |
| Independent | Independent of the subject |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (7)
FactCell Viability: NK cell therapy viability acceptance range = ≥70% in all reviewed Phase 1/2 trials; assay protocols were not harmonized across trials %AnswerHow is cell viability percentage calculated?AnswerWhat is an acceptable cell viability for cell therapy products?AnswerTrypan blue vs MTT: which cell viability assay should I use?AnswerWhy does cell viability drop after thawing cryopreserved cells?AnswerDoes higher cell viability mean better fat graft survival?ArticleCell Viability: Definition, Assays, Acceptance Criteria and Limits of Interpretation